Semin Neurol 2007; 27(3): 233-243
DOI: 10.1055/s-2007-979684
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Optic Disc Edema

Gregory P. Van Stavern1
  • 1Department of Ophthalmology, Neurology, and Neurosurgery, Wayne State University, Detroit, Michigan
Further Information

Publication History

Publication Date:
18 June 2007 (online)

ABSTRACT

Optic disc edema is the end result of many pathological processes, some relatively benign, some with devastating visual and neurological consequences. Differentiating among the various etiologies depends on a thorough history and complete examination with careful attention to the optic disc. Papilledema implies disc swelling due to elevated intracranial pressure, and can be distinguished from other causes of disc edema by clinical features. Congenitally anomalous optic discs may appear swollen, and proper recognition may spare patients unnecessary testing. The pathogenesis of disc swelling remains subject to debate, but the ultimate mechanism is backflow of axoplasmic transport. The treatment strategy for disc edema highly depends on the underlying etiology.

REFERENCES

  • 1 Digre K B, Corbett J J. Practical Viewing of the Optic Disc. Burlington, VT; Butterworth-Heinemann 2003
  • 2 Beck R W, Servais G E, Hayreh S S. Anterior ischemic optic neuropathy: IX. Cup-to-disc ratio and its role in pathogenesis.  Ophthalmology. 1987;  94 1503-1508
  • 3 Wirtschafter J D, Rizzo F J, Smiley C. Optic nerve axoplasm and papilledema.  Surv Ophthalmol. 1975;  20 157-189
  • 4 Tso M O, Hayreh S S. Optic disc edema in raised intracranial pressure: IV. Axoplasmic transport in experimental papilledema.  Arch Ophthalmol. 1977;  95 1458-1462
  • 5 Rosenberg M A, Savino P J, Glaser J S. A clinical analysis of pseudopapilledema: I. Population, laterality, acuity, refractive error, ophthalmoscopic characteristics, and coincident disease.  Arch Ophthalmol. 1979;  97 65-70
  • 6 Galvin J A, Van Stavern G P. Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center.  J Neurol Sci. 2004;  223 157-160
  • 7 Sadun A A, Curie J N, Lessell S. Transient visual obscurations with elevated optic discs.  Ann Neurol. 1984;  16 489-494
  • 8 Frisen L. Swelling of the optic nerve head: a staging scheme.  J Neurol Neurosurg Psychiatry. 1982;  45 13-18
  • 9 Hayreh M S, Hayreh S S. Optic disc edema in raised intracranial pressure: I. Evolution and resolution.  Arch Ophthalmol. 1977;  95 1237-1244
  • 10 Levin B E. The clinical significance of spontaneous pulsations of the retinal vein.  Arch Neurol. 1978;  35 37-40
  • 11 Paton L, Holmes G. The pathology of papilloedema: a histological study of sixty eyes.  Brain. 1911;  33 389-432
  • 12 Cartlidge N F, Ng R C, Tilley P J. Dilemma of the swollen optic disc: a fluorescein angiography study.  Br J Ophthalmol. 1977;  61 385-389
  • 13 Brodsky M C. Congenital anomalies of the optic disc. In: Miller NR, Newman NJ Walsh and Hoyt's Clinical Neuro-Ophthalmology. 6th ed. Philadelphia; Lippincott Williams & Wilkins 2005: 151-197
  • 14 Mullie M A, Sanders M D. Scleral canal size and optic nerve head drusen.  Am J Ophthalmol. 1985;  99 356-359
  • 15 Kurz-Levin M M, Landau K. A comparison of imaging techniques for diagnosing drusen of the optic nerve head.  Arch Ophthalmol. 1999;  117 1045-1049
  • 16 Taylor D. Congenital tumors of the anterior visual pathways.  Br J Ophthalmol. 1982;  66 455-463
  • 17 Straatsma B R, Foos F Y, Heckenlively J R, Taylor G N. Myelinated retinal nerve fibers.  Am J Ophthalmol. 1981;  91 25-38
  • 18 Fry W E. The pathology of papilledema: an examination of 40 eyes with special references to compression of the central retinal vein.  Am J Ophthalmol. 1931;  14 874-883
  • 19 van Heuven J A, Fischer P F. The water binding of the optic nerve and its sheaths.  Br J Ophthalmol. 1936;  20 204
  • 20 Rosomoff H L, Zugibe F T. Distribution of intracranial contents in experimental edema.  Arch Neurol. 1963;  9 26-34
  • 21 Hedges T R, Weinstein J D. The hydrostatic mechanism of papilledema.  Trans Am Acad Ophthalmol Otolaryngol. 1968;  72 741-750
  • 22 Sanders M D. The Bowman Lecture. Papilloedema: the pendulum of progress.  Eye. 1997;  11 267-294
  • 23 Brodsky M C, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri.  Ophthalmology. 1998;  105 1686-1693
  • 24 Hayreh S S. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc.  Br J Ophthalmol. 1969;  53 721-748
  • 25 Taylor A C, Weiss P. Demonstration of axonal flow by the movement of tritium-labeled protein in mature optic nerve fibers.  Proc Natl Acad Sci USA. 1965;  54 1521-1527
  • 26 Hayreh S S. Optic disc edema in raised intracranial pressure: V. Pathogenesis.  Arch Ophthalmol. 1977;  95 1553-1565
  • 27 Durcan F J, Corbett J J, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana.  Arch Neurol. 1988;  45 875-877
  • 28 Radhakrishnan K, Thacker A K, Bohlaga N H, Maloo J C, Gerryo S E. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study.  J Neurol Sci. 1993;  116 18-28
  • 29 Friedman D I, Jacobson D M. Diagnostic criteria for idiopathic intracranial hypertension.  Neurology. 2002;  59 1492-1495
  • 30 Biousse V, Ameri A, Bousser M G. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis.  Neurology. 1999;  53 1537-1542
  • 31 Corbett J J, Thompson H S. The rational management of idiopathic intracranial hypertension.  Arch Neurol. 1989;  46 1049-1051
  • 32 Wall M, George D. Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy.  Arch Neurol. 1987;  44 170-175
  • 33 Green G J, Lessell S, Loewenstein J I. Ischemic optic neuropathy in chronic papilledema.  Arch Ophthalmol. 1980;  98 502-504
  • 34 Optic Neuritis Study Group . The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial.  Arch Ophthalmol. 1991;  109 1673-1678
  • 35 Golnik K C, Marotto M E, Fanous M M et al.. Ophthalmic manifestations of Rochalimaea species.  Am J Ophthalmol. 1994;  118 145-151
  • 36 Wong T Y, Larsen E K, Klein R et al.. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities and Cardiovascular Health Studies.  Ophthalmology. 2005;  112 540-547
  • 37 Powell J, Van Stavern G P. Neuro-ophthalmic manifestations of systemic disease: hematology.  Ophthalmol Clin North Am. 2004;  17 371-388
  • 38 Arnold A C. Ischemic optic neuropathies.  Ophthalmol Clin North Am. 2001;  14 83-98
  • 39 Dutton J J. Optic nerve sheath meningiomas.  Surv Ophthalmol. 1992;  37 167-183

Gregory P Van StavernM.D. 

Director of Neuro-Ophthalmology, Kresge Eye Institute

4717 St. Antoine Blvd., Detroit, MI 48201

    >